<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04214769</url>
  </required_header>
  <id_info>
    <org_study_id>403-19</org_study_id>
    <nct_id>NCT04214769</nct_id>
  </id_info>
  <brief_title>Effect of Radiation Therapy Among Head and Neck Cancer Patients on the Inner Ear Function</brief_title>
  <official_title>Evaluation of the Effect of Radiation Therapy Among Head and Neck Cancer Patients on the Inner Ear Function Using Novel Techniques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tel-Aviv Sourasky Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tel-Aviv Sourasky Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aims: 1. To evaluate the effects of radiation therapy on the inner ear, among patients
      treated with radiation therapy for head and neck cancers using a wide battery of tests
      (Audiometry and tympanometry, vHIT, VEMP, ENG) ; 2. To correlate the mean total radiation
      dose to the cochlea with the effects on audiological and vestibular function
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Audiometry</measure>
    <time_frame>1.5 Year</time_frame>
    <description>The change in hearing threshold and in the speech-audiometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ENG test</measure>
    <time_frame>1.5 Year</time_frame>
    <description>Abnormal function of the central vestibular pathways, unilateral weakness of the vestibular apparatus or direction preponderance</description>
  </primary_outcome>
  <primary_outcome>
    <measure>VEMP test</measure>
    <time_frame>1.5 Year</time_frame>
    <description>Abnormal latencies, amplitudes, thresholds</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vHIT test</measure>
    <time_frame>1.5 Year</time_frame>
    <description>abnormal gain, the appearance of overt and covert saccades</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">17</enrollment>
  <condition>Head and Neck Cancer Patients Treated With Radiotherapy</condition>
  <arm_group>
    <arm_group_label>Head and Neck Cancer patients</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Audiometry and tympanometry, vHIT, VEMP, ENG</intervention_name>
    <description>Diagnostic tests</description>
    <arm_group_label>Head and Neck Cancer patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed Head and Neck cancers, not treated previously, and planned for radiation
        therapy in which the inner ear will be radiated
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Females and males, Age: â‰¥ 18 years old

          -  Patients diagnosed Head and Neck cancers, not treated previously

          -  Planned for radiation therapy in which the inner ear will be radiated

        Exclusion Criteria:

          -  Patients who were previously diagnosed with a vestibular disorder

          -  Previous middle or inner ear anomaly

          -  Failure to complete the whole course of radiation therapy

          -  More than one course of radiation therapy

          -  Patients treated with concurrent ototoxic chemotherapy

          -  Pregnant women

          -  Patients who will not sign an informed consent form

          -  Helpless or incompetent patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Yahav Oron, MD</last_name>
    <phone>973236973573</phone>
    <email>oron.yahav@gmail.com</email>
  </overall_contact>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>December 28, 2019</study_first_submitted>
  <study_first_submitted_qc>December 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 2, 2020</study_first_posted>
  <last_update_submitted>December 28, 2019</last_update_submitted>
  <last_update_submitted_qc>December 28, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Head and Neck Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

